Phase II study of the combination of Cisplatin + Temozolomide in malignant glial tumours in children and adolescents at diagnosis or in relapse. CNS 2004 02.

Trial Profile

Phase II study of the combination of Cisplatin + Temozolomide in malignant glial tumours in children and adolescents at diagnosis or in relapse. CNS 2004 02.

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jun 2013

At a glance

  • Drugs Cisplatin (Primary) ; Temozolomide (Primary)
  • Indications Glioma
  • Focus Therapeutic Use
  • Acronyms CISTEM
  • Most Recent Events

    • 22 Jun 2013 Last checked against ClinicalTrials.gov record (NCT00147160).
    • 22 Jun 2013 Last checked against ClinicalTrials.gov record (NCT00147160).
    • 10 Apr 2012 Actual end date Dec 2007 added as reported by ClinicalTrials.gov (NCT00147160).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top